Myostatin: Biology and Clinical Relevance

Author(s): Gilles Carnac, Stephanie Ricaud, Barbara Vernus, Anne Bonnieu.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 6 , Issue 7 , 2006

Become EABM
Become Reviewer


Myostatin is a negative regulator of muscle mass. Important advances in our understanding of thecomplex biology of this factor have revealed the therapeutic potential of antagonizing the myostatin pathway. Herewe present the rationale for evaluating anti-myostatin therapies in human muscle-wasting disorders.

Keywords: Myostatin, Muscle, Adipose tissue, Rhabdomyosarcoma, Myostatin antagonism, Myostatin processing and signaling, therapeutic approaches

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [765 - 770]
Pages: 6
DOI: 10.2174/138955706777698642
Price: $58

Article Metrics

PDF: 26